BidaskClub upgraded shares of LHC Group (NASDAQ:LHCG) from a buy rating to a strong-buy rating in a research note published on Friday morning, BidAskClub reports.

Other analysts have also issued research reports about the stock. Zacks Investment Research lowered shares of LHC Group from a hold rating to a sell rating in a research report on Thursday, May 2nd. UBS Group set a $133.00 target price on shares of LHC Group and gave the stock a buy rating in a research report on Friday, May 10th. Barclays raised their target price on shares of LHC Group from $95.00 to $104.00 and gave the stock an equal weight rating in a research report on Thursday, March 21st. Royal Bank of Canada raised their target price on shares of LHC Group to $130.00 and gave the stock an outperform rating in a research report on Monday, May 13th. Finally, Jefferies Financial Group raised their target price on shares of LHC Group from $125.00 to $130.00 and gave the stock a buy rating in a research report on Thursday, May 9th. Four investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. LHC Group presently has a consensus rating of Buy and a consensus price target of $118.50.

Shares of NASDAQ LHCG opened at $120.55 on Friday. LHC Group has a 1 year low of $73.09 and a 1 year high of $122.20. The company has a market cap of $3.72 billion, a P/E ratio of 33.96, a PEG ratio of 2.01 and a beta of 0.87. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.21.

LHC Group (NASDAQ:LHCG) last announced its earnings results on Wednesday, May 8th. The health services provider reported $0.98 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.90 by $0.08. LHC Group had a net margin of 3.83% and a return on equity of 8.43%. The firm had revenue of $502.59 million for the quarter, compared to analyst estimates of $511.16 million. Sell-side analysts anticipate that LHC Group will post 4.3 earnings per share for the current year.

In other LHC Group news, CEO Keith G. Myers sold 75,000 shares of LHC Group stock in a transaction on Friday, March 1st. The shares were sold at an average price of $108.53, for a total value of $8,139,750.00. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO Donald Dwayne Stelly sold 15,151 shares of LHC Group stock in a transaction on Monday, March 11th. The shares were sold at an average price of $107.06, for a total transaction of $1,622,066.06. Following the completion of the transaction, the chief operating officer now owns 92,065 shares in the company, valued at approximately $9,856,478.90. The disclosure for this sale can be found here. In the last quarter, insiders sold 118,324 shares of company stock worth $12,816,300. 5.20% of the stock is owned by company insiders.

Institutional investors and hedge funds have recently made changes to their positions in the business. Parallel Advisors LLC boosted its holdings in shares of LHC Group by 790.0% in the 1st quarter. Parallel Advisors LLC now owns 267 shares of the health services provider’s stock valued at $30,000 after purchasing an additional 237 shares during the last quarter. Sageworth Trust Co acquired a new position in shares of LHC Group in the 1st quarter valued at $36,000. Financial Gravity Companies Inc. acquired a new position in shares of LHC Group in the 4th quarter valued at $49,000. Quadrant Capital Group LLC boosted its holdings in shares of LHC Group by 1,045.7% in the 1st quarter. Quadrant Capital Group LLC now owns 527 shares of the health services provider’s stock valued at $57,000 after purchasing an additional 481 shares during the last quarter. Finally, Meeder Asset Management Inc. acquired a new position in shares of LHC Group in the 1st quarter valued at $68,000. Institutional investors own 94.07% of the company’s stock.

About LHC Group

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Featured Story: Outstanding Shares, Buying and Selling Stocks

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.